Phenotypes of Myocardial Dysfunction in Young Patients
https://doi.org/10.31550/1727-2378-2024-23-8-52-58
Abstract
Aim. To assess the risk of chronic cardiac failure (CCF) in young patients with metabolic syndrome.
Key points. Materials were searched in RSCI (Russian Science Citation Index), PubMed, Clinical Evidence, Cochrane Library, which allow for fast and efficient search for systematic reviews and prevent systemic errors.
Assessment of the risk of CCF development in young people, especially those with metabolic syndrome, is crucial for informed decisionmaking. In order to identify groups with a higher risk of CCF in young people, a screening algorithm is needed, which accounts for modifiable risk factors and heredity. Currently, there is no patient-specific algorithm to assess the estimated CCF development in young patients with various risk factors.
Conclusion. An important task is to develop and standardise patient-specific risk measures for CCF in the young population, primarily for those with metabolic syndrome.
About the Authors
L. D. Khidirova
Novosibirsk State Medical University of the Ministry of Health of Russia; Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation
Russian Federation
Novosibirsk
O. V. Dunischeva
Novosibirsk State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Novosibirsk
N. P. Ilynykh
Novosibirsk State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Novosibirsk
References
1. Polyakov D.S., Fomin I.V., Belenkov Yu.N., Mareev V.Yu. et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4–14. (in Russian). DOI: 10.18087/cardio.2021.4.n1628
2. Lecoeur E., Domeng O., Fayol A., Jannot A.S. et al. Epidemiology of heart failure in young adults: a French nationwide cohort study. Eur. Heart J. 2023;44(5):383–92. DOI: 10.1093/eurheartj/ehac651
3. Drapkina O.M., Boytsov S.A., Omelyanovskiy V.V., Kontsevaya A.V. et al. Socio-economic impact of heart failure in Russia. Russian Journal of Cardiology. 2021;26(6):4490. (in Russian). DOI: 10.15829/1560-4071-2021-4490
4. Basic C., Rosengren A., Dahlström U., Edner M. et al. Sex-related differences among young adults with heart failure in Sweden. Int. J. Cardiol. 2022;362:97–103. DOI: 10.1016/j.ijcard.2022.04.073
5. Tromp J., Paniagua S.M.A., Lau E.S., Allen N.B. et al. Age dependent associations of risk factors with heart failure: pooled population based cohort study. BMJ. 2021;372:461. DOI: 10.1136/bmj.n461
6. Rosengren A., Åberg M., Robertson J., Waern M. et al. Body weight in adolescence and long-term risk of early heart failure in adulthood among men in Sweden. Eur. Heart J. 2017;38(24):1926–33. DOI: 10.1093/eurheartj/ehw221
7. Khidirova L.D., Khayurina T.B., Demina A.S. Clinical and functional status of the cardiovascular system in military aged men. Doctor.Ru. 2023;22(8):29–32. (in Russian). DOI: 10.31550/1727-2378-2023-22-8-29-32
8. Kostyuchenko Yu.R., Potupchik T.V., Evert L.S., Panicheva E.S. et al. Social and metabolic risk factors for hypertension in adolescents. Doctor.Ru. 2023;22(3):70–5. (in Russian). DOI: 10.31550/1727-2378-2023-22-3-70-75
9. Shin D., Choi J.M., Lee H.Y. Suboptimal control status of young hypertensive population. Clin. Hypertens. 2023;29(1):13. DOI: 10.1186/s40885-023-00237-6
10. Ramakrishnan S., Zachariah G., Gupta K., Rao J.S. et al. Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey. Indian Heart J. 2019;71(4):309–13. DOI: 10.1016/j.ihj.2019.09.012
11. Okubadejo N.U., Ozoh O.B., Ojo O.O., Akinkugbe A.O. et al. Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: a comparative analysis based on recent guideline recommendations. Clin. Hypertens. 2019;25:7. DOI: 10.1186/s40885-019-0112-1
12. Wong C.M., Hawkins N.M., Ezekowitz J.A., Jhund P.S. et al. Heart failure in young adults is associated with high mortality: a contemporary population-level analysis. Can. J. Cardiol. 2017;33(11):1472–77. DOI: 10.1016/j.cjca.2017.05.009
13. Daniels S.R. Hypertension-induced cardiac damage in children and adolescents. Blood Press. Monit. 1999:4(3–4):165–70.
14. Carbone S., Lavie C.J., Elagizi A., Arena R. et al. The impact of obesity in heart failure. Heart Fail. Clin. 2020;16(1):71–80. DOI: 10.1016/j.hfc.2019.08.008
15. Tromp J., MacDonald M.R., Tay W.T., Teng T.H.K. et al. Heart failure with preserved ejection fraction in the young. Circulation. 2018;138(24):2763–73. DOI: 10.1161/CIRCULATIONAHA.118.034720
16. Reznik E.V., Ushakova N.A., Ershov N.S., Krupnova E.S. et al. Gender- and age-specific characteristics of patients with chronic heart failure in real clinical practice. Russian Medical Inquiry. Medical review. 2023;7(1):13–21. (in Russian). DOI: 10.32364/2587-6821-2023-7-1-13-21
17. Benn M., Marott S.C.W., Tybjærg-Hansen A., Nordestgaard B.G. Obesity increases heart failure incidence and mortality: observational and Mendelian randomization studies totalling over 1 million individuals. Cardiovasc. Res. 2023;118(18):3576–85. DOI: 10.1093/cvr/cvab368
18. Miklishanskaya S.V., Mazur N.A. Types of obesity and their impact on long-term outcomes in patients with cardiovascular disease. Obesity and Metabolism. 2021;18(2):125–31. (in Russian). DOI: 10.14341/omet12367
19. Bichurin D.R., Tsybusov A.P., Cherepanova O.A. Diabetes mellitus as a regional healthcare problem. International Scientific Research Journal. 2024;1(139). (in Russian). DOI: 10.23670/IRJ.2024.139.80
20. Sun H., Saeedi P., Karuranga S., Pinkepank M. et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119. Epub. 2021 Dec. 6. DOI: 10.1016/j.diabres.2021.109119
21. Drozdz D., Alvarez-Pitti J., Wójcik M., Borghi C. et al. Obesity and cardiometabolic risk factors: from childhood to adulthood. Nutrients. 2021;13(11):4176. DOI: 10.3390/nu13114176
22. Ovsyannikova A.K., Galenok R.B., Rymar O.D. Key principles of differential diagnosis of diabetes mellitus types in young patients. Doctor.Ru. 2023;22(4):24–8. (in Russian). DOI: 10.31550/17272378-2023-22-4-24-28
23. Оvsyannikova А.K., Zubareva D.Y. Features of the course of type 2 diabetes mellitus in young people. Medical Council. 2022;16(10):57–61. (in Russian). DOI: 10.21518/2079-701X-2022-16-10-57-61
24. Powell-Wiley T.M., Poirier P., Burke L.E., Després J.P. et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–1010. DOI: 10.1161/CIR.0000000000000973
25. Popyhova E.B., Stepanova T.V., Lagutina D.D., Kiriiazi T.S. et al. The role of diabetes in the onset and development of endothelial dysfunction. Problems of Endocrinology. 2020;66(1):47–55. (in Russian). DOI: 10.14341/probl12212
26. Ormazabal V., Nair S., Elfeky O., Aguayo C. et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol. 2018;17(1):122. DOI: 10.1186/s12933-0180762-4
27. Kim O.T., Dadaeva V.A., Drapkina O.M. Origins of obesity. The Russian Journal of Preventive Medicine. 2022;25(8):105–13. (in Russian). DOI: 10.17116/profmed202225081105
28. Veretyuk V.V., Tsygankova O.V., Ametov A.S. Evaluation of a cardiovascular risk in young men. Doctor.Ru. 2023;22(4):7–17. (in Russian). DOI: 10.31550/1727-2378-2023-22-4-7-17
29. Tsygankova O.V., Veretyuk V.V. Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives. Russian Journal of Cardiology. 2021;26(4):4436. (in Russian). DOI: 10.15829/1560-4071-2021-4436
30. Liang J., Li Y., Chen L., Xia W. et al. Systemic microvascular rarefaction is correlated with dysfunction of late endothelial progenitor cells in mild hypertension: a substudy of EXCAVATIONCHN1. J. Transl. Med. 2019;17(1):368. DOI: 10.1186/s12967-019-2108-8
31. Khidirova L.D., Karavozova A.E., Khachaturyan R.A. Impact of SGLT2 inhibitors on erythropoiesis and iron exchange in patients with diabetes mellitus and chronic heart failure. Russian Journal of Preventive Medicine. 2024;27(5):103–10. (in Russian). DOI: 10.17116/profmed202427051103
32. Khan S.S., Ning H., Shah S.J., Yancy C.W. et al. 10-Year risk equations for incident heart failure in the general population. J. Am. Coll. Cardiol. 2019;73(19):2388–97. DOI: 10.1016/j.jacc.2019.02.057
33. Khan S.S., Ning H., Allen N.B., Carnethon M.R. Development and validation of a long-term incident heart failure risk model. Circ. Res. 2022;130(2):200–9. Epub. 2021 Dec. 10. DOI: 10.1161/CIRCRESAHA.121.319595
34. Balanova Yu.A., Imaeva A.E., Kutsenko V.A., Kapustina A.V. et al. Metabolic syndrome and its associations with socio-demographic and behavioral risk factors in the Russian population aged 25–64 years. Cardiovascular Therapy and Prevention. 2020;19(4):2600. (in Russian). DOI: 10.15829/1728-8800-2020-2600
Review
For citations:
Khidirova L.D., Dunischeva O.V., Ilynykh N.P. Phenotypes of Myocardial Dysfunction in Young Patients. Title. 2024;23(8):52-58. (In Russ.) https://doi.org/10.31550/1727-2378-2024-23-8-52-58
Views:
20
Email this article 